HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
SINT
Sintx Technologies, Inc.
There isn't enough reported data to score SINT yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
SINT Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
SINT's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
SINT PE Valuation
SINT has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
SINT Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect SINT's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
SINT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.19 | +$7.98 |
| Q2 2026 | -$5.41 | +$8.26 |
| Q1 2026 | -$5.57 | +$10.80 |
| Q4 2025 | -$6.16 | +$30.92 |
| Q3 2025 | -$10.17 | +$153.79 |
| Q2 2025 | -$13.67 | +$305.33 |
| Q1 2025 | -$16.37 | +$455.02 |
SINT has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over SINT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over SINT on profitability, with a higher operating margin.
SINT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2M | +953% |
| Q2 2026 | $452K | +199% |
| Q1 2026 | $380K | +3% |
| Q4 2025 | $290K | -46% |
| Q3 2025 | $208K | -74% |
| Q2 2025 | $151K | -82% |
| Q1 2025 | $369K | -46% |
| Q4 2024 | $542K | -40% |
SINT's revenue is growing: $2M last quarter, up 953% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -75% | +1538 points |
| Q2 2026 | -639% | +1126 points |
| Q1 2026 | -844% | -198 points |
| Q4 2025 | -799% | -480 points |
| Q3 2025 | -1613% | -811 points |
| Q2 2025 | -1765% | -1449 points |
| Q1 2025 | -646% | -180 points |
| Q4 2024 | -320% | -18 points |
SINT's operating margin was −75% last quarter, up 1538 points from the same quarter a year ago, near the top of its range since 2019.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over SINT on cash generation, producing positive trailing cash flow while its opponent burns cash.
SINT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.5M | +$1.1M |
| Q2 2026 | -$2.9M | -$442K |
| Q1 2026 | -$2.5M | -$1.1M |
| Q4 2025 | -$2.4M | -$1.1M |
| Q3 2025 | -$2.6M | -$20K |
| Q2 2025 | -$2.4M | +$165K |
| Q1 2025 | -$1.4M | +$1.5M |
| Q4 2024 | -$1.3M | +$1.9M |
SINT has burned cash in almost every quarter: −$9M over the past year, against −$8M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over SINT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
SINT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +37% | +1.8M shares |
| 1 year | +163% | +4.1M shares |
| 3 years | +29950% | +6.6M shares |
SINT has 7M diluted shares, up 163% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $47,000 |
| Q1 2025 | $86,000 |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
SINT Net Leverage
SINT's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
SINT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 17.8 | Oversold |
SINT's weekly RSI is 40 (neutral) and its Stochastic is 18 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
SINT PE vs Healthcare Sector
SINT has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
SINT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.79 | 14% below |
| 20 week MA | $1.71 | 9.9% below |
| 50 week MA | $2.39 | 36% below |
| 100 week MA | $2.86 | 46% below |
| 200 week MA | $92.7 | 98% below |
SINT is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over SINT on returns for 2026, with the stronger performance.
SINT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29,200.0 | $34,400.0 | +18% |
| 2021 | $34,400.0 | $14,000.0 | -59% |
| 2022 | $14,000.0 | $1,640.0 | -88% |
| 2023 | $1,640.0 | $76.3 | -95% |
| 2024 | $76.3 | $3.78 | -95% |
| 2025 | $3.78 | $3.74 | -1.1% |
| 2026 YTD | $3.74 | $1.54 | -59% |
SINT has finished five years in a row lower, and it's down 59% so far in 2026.